ARCHIVES

ODAC’s Dilemma: Proposed Indication Created By Reliance On PSA Screening and Hormonal Treatment

This article is from The Cancer Letter archive.

Vol. 37 No. 35 | September 23, 2011

Download PDF Visit The Full Archive

Related Articles

NCI to Close Clinical Branch at Frederick, Move Patients, Protocols To Bethesda

May 17, 1996

Avastin Improves PFS In Advanced Breast Cancer

April 29, 2005

Lasker Awards Announced

September 25, 2009

FDA Approves Evista for Breast Cancer Risk Reduction.

September 14, 2007

In Brief: RFPs For Recompeting Frederick Contract Still Being Drafted; Panel Meets April 13

April 10, 1981

The Cancer Letter Obtains “Confidential” Documents From Duke IRB Investigation

May 14, 2010